Clinical trial
Conducted AF-Response Study (Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation Treated With InSync III Marquis)
NCT00170313 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Conducted AF-Response Study (Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation Treated With InSync III Marquis)
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- December 31, 2003
- Completion date
- January 31, 2007
- Enrollment
- 100 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, heart failure, sudden cardiac death